Exact Sciences to participate in August investor conference

Rhea-AI Summary

Exact Sciences Corp. (EXAS) announced its upcoming participation in the UBS Genomics 2.0 and MedTech Innovations Summit on August 10, 2022, at 4:00 p.m. ET. The event will include a fireside chat, inviting investors to join via webcast. Exact Sciences, recognized for its innovative cancer screening and diagnostic tests, continues to seek advanced solutions for early cancer detection and treatment. The webcast will be accessible through their investor relations section at www.exactsciences.com.

AI-generated analysis. Not financial advice.

News Market Reaction – EXAS

+4.68%

1 alert

+4.68% News Effect

On the day this news was published, EXAS gained 4.68%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MADISON, Wis., Aug. 1, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

• UBS Genomics 2.0 and MedTech Innovations Summit, Dana Point
  Fireside chat on Wednesday, August 10, 2022 at 4:00 p.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.

About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard^® and Oncotype^® tests, Exact Sciences is investing in its product pipeline to support patients before and throughout their cancer diagnosis and treatment. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815

View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-august-investor-conference-301596625.html

SOURCE Exact Sciences Corporation

FAQ

What is Exact Sciences participating in on August 10, 2022?

Exact Sciences will participate in the UBS Genomics 2.0 and MedTech Innovations Summit on August 10, 2022.

What time is the Exact Sciences fireside chat scheduled for?

The fireside chat is scheduled for 4:00 p.m. ET on August 10, 2022.

How can I access the Exact Sciences webcast?

The webcast can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.

What company ticker symbol is associated with Exact Sciences?

The company ticker symbol for Exact Sciences is EXAS.

What products does Exact Sciences focus on for cancer screening?

Exact Sciences focuses on cancer screening and diagnostic tests, including Cologuard® and Oncotype® tests.